Dry Eye & Ocular Surface Espansione
meibomask®
Professional photobiomodulation mask for upper and lower eyelid treatment
- Totally non-invasive Near-infrared light on the skin, with no contact with the eye
- Upper and lower lids Mask covers both eyelids for a complete treatment
- Quick and easy Minimal training and no set-up time for the operator
- Guided by me-check® Energy and duration set from the me-check® severity result
Overview
meibomask® by Espansione is a professional light therapy device dedicated to LM™ LLLT, Espansione’s patented low-level light photobiomodulation technology. It is designed for practices that want to manage anterior segment conditions such as dry eye disease caused by meibomian gland dysfunction, chalazion and blepharitis. The mask covers both the upper and lower eyelids, so one session treats the full eyelid area. It shares the industrial design of the other Espansione solutions and needs minimal training.
How LM™ LLLT works
meibomask® emits near-infrared light onto the skin of the eyelids at a medically certified wavelength. According to Espansione, the light acts on the mitochondria in the cells, stimulating ATP production and generating gentle endogenous heat. This process is described as helping to increase and stabilise the tear lipid layer. The treatment is entirely non-invasive, and Espansione reports that patients often feel relief shortly after the session. Results vary between patients, and the practitioner plans the course of treatment.
Personalised with me-check®
meibomask® can deliver custom treatments based on the severity of meibomian gland dysfunction found with a me-check® screening. Depending on the degree of gland loss, it sets the amount of energy and the treatment duration for each patient. For the operator this means little set-up and consistent delivery from one session to the next. For practices that also need intense pulsed light, eye-light® combines LM™ LLLT with OPE™ IPL in one device.
Specifications
Technology
| Therapy | LM™ LLLT photobiomodulation |
|---|---|
| Light | Near-infrared, medically certified wavelength |
Treatment
| Coverage | Upper and lower eyelids |
|---|---|
| Session length | About 15 min |
| Personalisation | Energy and duration set from me-check® MGD severity |
Use
| Setting | In-practice, professional use |
|---|
Works with
Dry Eye & Ocular Surface
eye-light®
Dual light therapy platform combining LM™ LLLT and OPE™ IPL for eye care
What conditions is meibomask® used for?
Espansione designed it for anterior segment conditions including dry eye disease caused by meibomian gland dysfunction, chalazion and blepharitis.
How long is a treatment session?
About 15 minutes. The practitioner decides how many sessions each patient needs.
How is meibomask® different from eye-light®?
meibomask® offers LM™ LLLT only. eye-light® combines LM™ LLLT with OPE™ IPL in one platform.
Talk to us
Ask about the meibomask®
Tell us what you need: a quote, a demonstration in your practice, finance options or a brochure. Your regional representative will reply within one working day.
Your Essilor Instruments team
Speak to the representative for your province, or call the Johannesburg office on +27 87 365 2077.
Free State, Gauteng, North West, Limpopo, Mpumalanga
Ritchard Dry
Regional representative
Northern Cape, Western Cape, Eastern Cape, KwaZulu-Natal
Stephan du Plessis
Regional representative